TherapeuticsMD Inc (NASDAQ:TXMD) – Research analysts at Oppenheimer lowered their Q3 2018 EPS estimates for shares of TherapeuticsMD in a report released on Wednesday, May 30th. Oppenheimer analyst J. Olson now forecasts that the company will post earnings per share of ($0.09) for the quarter, down from their previous estimate of ($0.08). Oppenheimer currently has […]
